These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23837872)

  • 1. Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes.
    Bledsoe TJ; Noble AR; Hunter GK; Rybicki LA; Hoschar A; Chute DJ; Saxton JP; Greskovich JF; Adelstein DJ; Koyfman SA
    Radiat Oncol; 2013 Jul; 8():174. PubMed ID: 23837872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy.
    Naik M; Ward MC; Bledsoe TJ; Kumar AM; Rybicki LA; Saxton JP; Burkey BB; Greskovich JF; Adelstein DJ; Koyfman SA
    Oral Oncol; 2015 Aug; 51(8):800-4. PubMed ID: 25977228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study.
    Kelly JR; Park HS; An Y; Contessa JN; Yarbrough WG; Burtness BA; Decker R; Husain Z
    JAMA Oncol; 2017 Aug; 3(8):1107-1111. PubMed ID: 28056116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
    Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer.
    Hasegawa M; Maeda H; Deng Z; Kiyuna A; Ganaha A; Yamashita Y; Matayoshi S; Agena S; Toita T; Uehara T; Suzuki M
    Int J Oncol; 2014 Sep; 45(3):1017-26. PubMed ID: 24969413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Mizumachi T; Kano S; Sakashita T; Hatakeyama H; Suzuki S; Homma A; Oridate N; Fukuda S
    Int J Clin Oncol; 2013 Oct; 18(5):824-8. PubMed ID: 22936564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGSF4 methylation as an independent marker of human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Chen KM; Stephen JK; Havard S; Mahan M; Divine G; Worsham MJ
    JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):257-63. PubMed ID: 25569158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
    Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
    Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
    Oliva M; Schneeberger PHH; Rey V; Cho M; Taylor R; Hansen AR; Taylor K; Hosni A; Bayley A; Hope AJ; Bratman SV; Ringash J; Singh S; Weinreb I; Perez-Ordoñez B; Chepeha D; Waldron J; Xu W; Guttman D; Siu LL; Coburn B; Spreafico A
    Br J Cancer; 2021 Apr; 124(9):1543-1551. PubMed ID: 33750907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
    Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
    Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer.
    Dave E; Ozbek U; Gupta V; Genden E; Miles B; Teng M; Posner M; Misiukiewicz K; Bakst RL
    PLoS One; 2017; 12(7):e0181108. PubMed ID: 28732044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
    Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
    Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
    Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy.
    Sher DJ; Thotakura V; Balboni TA; Norris CM; Haddad RI; Posner MR; Lorch J; Goguen LA; Annino DJ; Tishler RB
    Ann Oncol; 2012 Sep; 23(9):2391-2398. PubMed ID: 22425872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.